Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
Desai, Neil P, Trieu, Vuong, Hwang, Larn Yuan, Wu, Rujin, Soon-Shiong, Patrick, Gradishar, William J
Published in Anti-cancer drugs (01.10.2008)
Published in Anti-cancer drugs (01.10.2008)
Get more information
Journal Article
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, Leeju C, Wang, Zhuo Wei, Tsan, Julia Tsou, Spillman, Monique A, Phung, Anne, Xu, Xie L, Yang, Meng-Chun W, Hwang, Larn-Yuan, Bowcock, Anne M, Baer, Richard
Published in Nature genetics (01.12.1996)
Published in Nature genetics (01.12.1996)
Get full text
Journal Article
Abstract 5029: OT-101/Chemotherapy- A novel mechanism of action (MOA) in glioblastoma immunization therapy
Hwang, Larn, Nam, David, Uckun, Fatih, Trieu, Vuong
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
ATIM-06. TREATMENT OF RECURRENT/REFRACTORY (R/R) ANAPLASTIC ASTROCYTOMA (AA, WHO GRADE 3) PATIENTS WITH ANTI-TGFß2 RNA THERAPEUTIC OT-101 VERSUS TEMOZOLOMIDE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL
Uckun, Fatih, Qazi, Sanjive, Nam, David, Hwang, Larn, Trieu, Vuong
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Get full text
Journal Article
ATIM-10. CLINICAL PREDICTORS OF RESPONSE FOR RECURRENT/REFRACTORY GLIOBLASTOMA MULTIFORME (GBM) AND ANAPLASTIC ASTROCYTOMA (AA, WHO GRADE III) PATIENTS TREATED WITH THE ANTI-TGFß2 RNA THERAPEUTIC OT-101
Qazi, Sanjive, Nam, David, Hwang, Larn, Trieu, Vuong, Uckun, Fatih
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Get full text
Journal Article
ATIM-03. ANTI-TGFß2 RNA THERAPEUTIC OT-101 INDUCES DURABLE OBJECTIVE RESPONSES IN PATIENTS WITH RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA MULTIFORME (GBM, WHO GRADE 4) OR ANAPLASTIC ASTROCYTOMA (AA, WHO GRADE 3)
Uckun, Fatih, Qazi, Sanjive, Hwang, Larn, Nam, David, Trieu, Vuong
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Get full text
Journal Article
Abstract 3742: Treatment with trabedersen, an anti-TGF-beta 2 antisense, primed tumors to subsequent chemotherapies
Hwang, Larn, Ng, Kevin, Wang, Wen, Trieu, Vuong
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
OT-101: An anti-TGF-beta-2 antisense- primed tumors to subsequent chemotherapies
Hwang, Larn, Ng, Kevin, Wang, Wen, Trieu, Vuong N.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Preclinical and Clinical Studies on Safety of CEQ508 Bacteria Engineered to Deliver Short-Hairpin RNA to Mediate RNA Interference Against β-catenin in the GI Tract of Patients With Familial Adenomatous Polyposis: 297
DʼCruz, Osmond, Hwang, Larn, Fong, Annie, Ng, Kevin, Nam, David, Wang, Wen, Trieu, Vuong
Published in The American journal of gastroenterology (01.10.2017)
Published in The American journal of gastroenterology (01.10.2017)
Get full text
Journal Article
Abstract 1600: Interleukin-8 (IL-8) in TGF-β immunotherapy and chemotherapies
Hwang, Larn, Ng, Kevin, D’Cruz, Osmond, Qazi, Sanjive, Schmidt, Andrew, Trieu, Vuong
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article